AADI - Aadi Bioscience, Inc.
IEX Last Trade
3.125
0 0%
Share volume: 2,298
Last Updated: Wed 15 Jan 2025 06:52:49 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.77%
PREVIOUS CLOSE
CHG
CHG%
$3.12
0.00
0.00%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-08 | 2023-08-09 | 2023-11-08 | 2024-11-06 | 2024-05-08 | 2024-08-07 | 2024-11-06 | |
| Assets | ||||||||
| Total Assets | 170.654 M | 151.228 M | 139.659 M | 132.423 M | 111.073 M | 101.620 M | 85.698 M | |
| Current Assets | 164.930 M | 144.923 M | 132.884 M | 124.586 M | 102.573 M | 93.005 M | 77.315 M | |
| Inventories | 3.803 M | 3.457 M | 3.615 M | 6.427 M | 5.936 M | 6.098 M | 5.468 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 117.128 M | 66.727 M | 50.532 M | 45.957 M | 34.491 M | 37.429 M | 32.082 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 34.046 M | 68.162 M | 68.803 M | 62.888 M | 53.780 M | 41.139 M | 30.537 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.225 M | 3.005 M | 3.601 M | 4.802 M | 5.686 M | 6.004 M | 5.982 M | |
| Other Assets | 3.499 M | 3.300 M | 3.174 M | 3.035 M | 2.814 M | 2.611 M | 2.401 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 170.654 M | 151.228 M | 139.659 M | 132.423 M | 111.073 M | 101.620 M | 85.698 M | |
| Total liabilities | 24.668 M | 19.809 M | 21.463 M | 27.228 M | 20.613 M | 22.829 M | 16.830 M | |
| Total current liabilities | 17.747 M | 12.996 M | 20.517 M | 26.395 M | 19.875 M | 22.147 M | 15.813 M | |
| Accounts Payable | 6.510 M | 2.898 M | 2.605 M | 5.898 M | 3.095 M | 2.265 M | 1.374 M | |
| Other liabilities | 6.921 M | 6.813 M | 946.000 K | 833.000 K | 738.000 K | 682.000 K | 1.017 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 6.921 M | 6.813 M | 946.000 K | 833.000 K | 738.000 K | 682.000 K | 1.017 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 145.986 M | 131.419 M | 118.196 M | 105.195 M | 90.460 M | 78.791 M | 68.868 M | |
| Common stock | 364.439 M | 367.855 M | 370.906 M | 374.131 M | 377.720 M | 380.653 M | 383.210 M | |
| Retained earnings | -218.421 M | -236.392 M | -252.694 M | -268.963 M | -287.252 M | -301.835 M | -314.381 M |